IL1B and malaria: Several studies have demonstrated the clinical relevance of IL-1RA in immune responses to malaria [65–68], which acts modulating disease severity by competing with the pro-inflammatory cytokines IL-1α and IL-1β for binding sites on the IL-1 type I receptor and inhibits IL-1 signalling [69].